Stockreport

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF SAN DIEGO, April 18, 2024 BUSINESS WIRE TriLink BioTechnologies (TriLink ® ), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents [Read more]